We’re halfway through January, so it seems a good time to start teasing one of the features for our upcoming issue: Meet the Editorial Advisory Board! This week, Ian Wilson tells us what makes him tick and talks about the move away from animal models in pharma. Also for your perusal: Tadeusz Górecki asks why GCxGC hasn’t been more widely adopted, and we chat omics, organoids and oncology with Amanda Hummon. There’s also a quick read on SARS-CoV-2 3D imaging. Enjoy!
Lauren Robertson, Deputy Editor
|